Nitrosamine and nicotine exposure after switching from filtered to unfiltered cigarette smoking: a cross-over clinical trial
Clinical Snapshot
PICO Framework
| P — Population | 29 adult cigarette smokers |
| I — Intervention | Unfiltered cigarette smoking |
| C — Comparator | Filtered cigarette smoking |
| O — Outcomes | Urinary cotinine and NNAL (4-[(methylnitrosamino])-1-[3-pyridyl]-1-butanol) biomarker levels |
Bottom Line
This small cross-over trial (n=29) found no significant differences in nicotine and nitrosamine biomarker exposure between filtered and unfiltered cigarettes. While the cross-over design strengthens internal validity, the study is severely limited by its small sample size and narrow focus on biomarkers alone. The inability to blind participants and absence of behavioural outcomes (smoking patterns, satisfaction, cessation attempts) are significant limitations. The authors suggest these findings support filter bans for environmental reasons, but the evidence is insufficient to guide clinical practice or policy. The study serves as proof-of-principle only, and the authors appropriately acknowledge that larger studies are needed. Clinicians should be cautious about extrapolating these limited findings to broader populations or using them to inform patient counselling about smoking cessation strategies.
Key Findings
P Value: Not significant (exact values not provided)
Effect Size: No significant differences between filtered and unfiltered cigarettes
Primary Outcome: Urinary cotinine and NNAL biomarker levels
Nnt Or Sensitivity: Not applicable - no significant treatment effect demonstrated
Confidence Interval: Not reported in abstract
Clinical Application
Limited by very small sample size and lack of behavioural outcome data Relevant to Australian tobacco control policy discussions, though TGA and ACCC would require larger studies before considering filter ban policies Current cigarette smokers, particularly relevant for policy discussions about filter bans
Abstract
BACKGROUND: The cellulose acetate filter is a plastic attachment on nearly all commercial cigarettes sold worldwide. It is the main component of discarded cigarette butts, and the most prevalent waste item collected during urban and beach cleanups. This waste leaches toxic chemicals, including nicotine, metals and tobacco-specific nitrosamines and contributes to environmental microplastic pollution. There is growing international interest in reducing plastic waste from single-use, non-essential products such as cellulose acetate cigarette filters. Public health and environmental advocates recommend a ban on the sale of filtered cigarettes to reduce environmental pollution caused by discarded cigarette butts and to discourage cigarette smoking. RESEARCH QUESTION: What potential health and behavioural implications might arise among people who smoke if filtered cigarettes are removed from the market. METHODS: We conducted a cross-over, randomised clinical trial of 29 people who smoke to evaluate changes in biomarkers for nicotine and tobacco-specific nitrosamine exposure when switching between filtered and unfiltered cigarette smoking. RESULTS: Although unfiltered smoking showed a higher trend in the geometric means of 4-[(methylnitrosamino])-1-[3-pyridyl]-1-butanol (NNAL) compared with filtered cigarettes, regression models for urinary cotinine and NNAL showed no significant differences when switching between filtered and unfiltered cigarettes. CONCLUSION: This proof-of-principle study suggests there is no increased risk to people who smoke when switching to unfiltered cigarette smoking. Although larger studies might provide more evidence regarding unfiltered cigarette smoking, banning the sale of filtered cigarettes may be an important policy intervention to both reduce hazardous tobacco waste and discourage smoking.
References
- 1.Appolon, G., Oren, E., Pulvers, K., Romero, D., Hoh, E., Dodder, N. G., Wong, J., Nynas, K., Tracey, L., Lemus, H., & Novotny, T. E. (2024). Nitrosamine and nicotine exposure after switching from filtered to unfiltered cigarette smoking: a cross-over clinical trial. Tobacco Control. https://doi.org/10.1136/tc-2024-058765
Related Research
PloS one
Factors associated with resilience among parents of children with autism spectrum disorder: A systematic review
23 June 2026
Cancer
Alcohol consumers' receptivity to artificial intelligence-generated alcohol-cancer risk messages: An experimental study.
15 June 2026
Human vaccines & immunotherapeutics
Immunogenicity and safety of AS03-adjuvanted A/Astrakhan/3212/2020 (H5N8)-like influenza vaccine in adults: Phase 1/2, observer-blinded, randomized trial
14 June 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service